AAV Vector-Mediated Deletion of Large Mutational Hotspot for Treatment of Duchenne Muscular Dystrophy
Copyright © Targeted News Service 2026
2026-05-19
ALEXANDRIA, Virginia, May 19 -- DUKE UNIVERSITY, Durham, North Carolina has been assigned a patent (No. US 12629428 B2, initially filed April 14, 2020) developed by three inventors Charles A. Gersbach, Chapel Hill, North Carolina; Karen Bulaklak, Durham, North Carolina; and Jacqueline N. Robinson-Hamm, Durham, North Carolina, for "AAV vector-mediated deletion of large mutational hotspot for treatment of Duchenne muscular dystrophy." . . .
